This Medical Letter review summarizes a newly approved extended-release, abuse-deterrent capsule formulation of oxycodone for pain management.
This noninferiority trial compares the effects of implanted vs sublingual buprenorphine for sustaining abstinence among adults with opioid dependence who achieved abstinence after 6 months or more of sublingual buprenorphine treatment.
This study assesses trends in the amount of hydrocodone/acetaminophen and oxycodone/acetaminophen prescribed for postoperative pain management.
This study examines the frequency of opioid prescriptions filled within 7 days of extraction among Medicaid patients.
This guideline from the Centers for Disease Control and Prevention makes 12 recommendations to improve communication about opioids for chronic pain, to improve the safety and effectiveness of pain treatment, and to reduce risks associated with long-term opioid therapy.
This Medical Letter review summarizes several opioid formulations that claim to deter abuse.